Found: 35
Select item for more details and to access through your institution.
In this issue: Graphical abstract.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2277, doi. 10.1111/all.15421
- Publication type:
- Article
Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2284, doi. 10.1111/all.15393
- By:
- Publication type:
- Article
Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2560, doi. 10.1111/all.15373
- By:
- Publication type:
- Article
T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2468, doi. 10.1111/all.15372
- By:
- Publication type:
- Article
Obituary in memory of Giovanni Pajno.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2578, doi. 10.1111/all.15368
- By:
- Publication type:
- Article
Dietary fiber and fermented food consumption and its link to allergic responses.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2568, doi. 10.1111/all.15367
- By:
- Publication type:
- Article
Corrigendum for "Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns".
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2576, doi. 10.1111/all.15335
- By:
- Publication type:
- Article
COVID‐19 in the absence of eosinophils: The outcome of confirmed SARS‐CoV‐2 infection whilst on treatment with benralizumab.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2558, doi. 10.1111/all.15334
- By:
- Publication type:
- Article
Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS‐CoV‐2: A longitudinal study.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2459, doi. 10.1111/all.15316
- By:
- Publication type:
- Article
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2446, doi. 10.1111/all.15311
- By:
- Publication type:
- Article
IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2555, doi. 10.1111/all.15326
- By:
- Publication type:
- Article
Selenomethionine attenuates allergic effector responses in human primary mast cells.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2552, doi. 10.1111/all.15320
- By:
- Publication type:
- Article
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2549, doi. 10.1111/all.15319
- By:
- Publication type:
- Article
A potential immunological silver bullet for COVID‐19: The trivalent chimpanzee adenoviral serotype‐68 vector (Tri:ChAd).
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2565, doi. 10.1111/all.15333
- By:
- Publication type:
- Article
Reply to correspondence to 'Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus'.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2574, doi. 10.1111/all.15330
- By:
- Publication type:
- Article
Development of the Cold Urticaria Activity Score.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2509, doi. 10.1111/all.15310
- By:
- Publication type:
- Article
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2431, doi. 10.1111/all.15305
- By:
- Publication type:
- Article
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2415, doi. 10.1111/all.15302
- By:
- Publication type:
- Article
Are health care policies for COVID‐19 evidence‐based?
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2290, doi. 10.1111/all.15297
- By:
- Publication type:
- Article
Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2287, doi. 10.1111/all.15283
- By:
- Publication type:
- Article
Correspondence to "Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus".
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2571, doi. 10.1111/all.15281
- By:
- Publication type:
- Article
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut‐specific immune responses.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2534, doi. 10.1111/all.15276
- By:
- Publication type:
- Article
Humoral immune response of BBIBP COVID‐19 vaccination before and after the booster immunization.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2404, doi. 10.1111/all.15271
- By:
- Publication type:
- Article
Managing the allergy and asthma epidemic in 2020s—Lessons from the Finnish experience.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2367, doi. 10.1111/all.15266
- By:
- Publication type:
- Article
Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2393, doi. 10.1111/all.15262
- By:
- Publication type:
- Article
Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross‐sectional multi‐center study.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2520, doi. 10.1111/all.15233
- By:
- Publication type:
- Article
Differential effects of lung inflammation on insulin resistance in humans and mice.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2482, doi. 10.1111/all.15226
- By:
- Publication type:
- Article
Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2355, doi. 10.1111/all.15261
- By:
- Publication type:
- Article
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2381, doi. 10.1111/all.15247
- By:
- Publication type:
- Article
House dust mite sensitization and exposure affects bronchial epithelial anti‐microbial response to viral stimuli in patients with asthma.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2498, doi. 10.1111/all.15243
- By:
- Publication type:
- Article
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2337, doi. 10.1111/all.15258
- By:
- Publication type:
- Article
COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2313, doi. 10.1111/all.15252
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2271, doi. 10.1111/all.14932
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2273, doi. 10.1111/all.14931
- Publication type:
- Article
Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2292, doi. 10.1111/all.15241
- By:
- Publication type:
- Article